Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 692

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function

Open access
Tzianabos, Arthur O.·2000·Clinical Microbiology Reviews
DOI 10.1128/cmr.13.4.523
Open this paper in CoChat — free account

Abstract

SUMMARY: Polysaccharide immunomodulators were first discovered over 40 years ago. Although very few have been rigorously studied, recent reports have revealed the mechanism of action and structure-function attributes of some of these molecules. Certain polysaccharide immunomodulators have been identified that have profound effects in the regulation of immune responses during the progression of infectious diseases, and studies have begun to define structural aspects of these molecules that govern their function and interaction with cells of the host immune system. These polymers can influence innate and cell-mediated immunity through interactions with T cells, monocytes, macrophages, and polymorphonuclear lymphocytes. The ability to modulate the immune response in an appropriate way can enhance the host's immune response to certain infections. In addition, this strategy can be utilized to augment current treatment regimens such as antimicrobial therapy that are becoming less efficacious with the advent of antibiotic resistance. This review focuses on recent studies that illustrate the structural and biologic activities of specific polysaccharide immunomodulators and outlines their potential for clinical use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/cmr.13.4.523

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 79

  1. Adams D. S. Pero S. C. Petro J. B. Nathans R. Mackin W. M. Wakshull E. PGG-glucan activates NF-kappaB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line. J. Leukoc. Biol. 62 1997 865 873 · DOI
  2. 10.1146/annurev.immunol.17.1.593 · DOI · Paper page
  3. Assenmacher M. Lohning M. Scheffold A. Manz R. A. Schmitz J. Radbruch A. Sequential production of IL-2, IFN-gamma and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes. Eur. J. Immunol. 28 1998 1534 1543 · doi:10.1002/(sici)1521-4141(199805)28:05<1534::aid-immu1534>3.0.co;2-r
  4. Babineau T. J. Hackford A. Kenler A. Bistrian B. Forse R. A. Fairchild P. G. Heard S. Keroack M. Caushaj P. Benotti P. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch. Surg. 129 1994 1204 1210 · DOI
  5. 10.1097/00000658-199411000-00002 · DOI
  6. Baumann H. Tzianabos A. O. Brisson J. R. Kasper D. L. Jennings H. J. Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using resolution NMR spectroscopy. Biochemistry 31 1992 4081 4089 · DOI · Paper page
  7. Blackstock R. Casadevall A. Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival. Immunology 92 1997 334 339 · DOI
  8. Bleicher P. Mackin W. Betafectin PGG-glucan: a novel carbohydrate immunomodulator with anti-infective properties. J. Biotechnol. Healthcare 2 1995 207 222
  9. Browder W. Williams D. Pretus H. Olivero G. Enrichens F. Mao P. Franchello A. Beneficial effect of enhanced macrophage function in the trauma patient. Ann. Surg. 211 1990 605 613
  10. Browder W. Williams D. Sherwood E. McNamee R. Jones E. DiLuzio N. Synergistic effect of nonspecific immunostimulation and antibiotics in experimental peritonitis. Surgery 102 1987 206 214
  11. Brubaker J. O. Li Q. Tzianabos A. O. Kasper D. L. Finberg R. W. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro. J. Immunol. 162 1999 2235 2242 · DOI
  12. Burgaleta C. Territo M. C. Quan S. G. Golde D. W. Glucan-activated macrophages: functional characteristics and surface morphology. J. Reticuloendothel. Soc. 23 1978 195 204
  13. Chen W. Y. Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen. 7 1999 79 89 · DOI · Paper page
  14. 10.1128/iai.64.6.2201-2205.1996 · DOI
  15. 10.1046/j.1440-1711.1999.00848.x · doi:10.1046/j.1440-1711.1999.00848.x
  16. Czop J. K. Austen K. F. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis. Proc. Natl. Acad. Sci. USA 82 1985 2751 2755 · doi:10.1073/pnas.82.9.2751
  17. Czop J. K. Austen K. F. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. J. Immunol. 135 1985 3388 3393 · DOI
  18. Dellinger E. P. Babineau T. J. Bleicher P. Kaiser A. B. Seibert G. B. Postier R. G. Vogel S. B. Norman J. Kaufman D. Galandiuk S. Condon R. E. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Arch. Surg. 134 1999 977 983 · DOI
  19. Delville J. Jacques P. J. Therapeutic effect of yeast glucan in mice infected with Mycobacterium leprae. Arch. Int. Physiol. Biochim. 85 1977 965 966
  20. DiLuzio N. R. Williams D. L. Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect. Immun. 20 1978 804 810 · DOI · Paper page
  21. Doita M. Rasmussen L. T. Seljelid R. Lipsky P. E. Effect of soluble aminated beta-1,3-d-polyglucose on human monocytes: stimulation of cytokine and prostaglandin E2 production but not antigen-presenting function. J. Leukoc. Biol. 49 1991 342 351 · doi:10.1002/jlb.49.4.342
  22. Garcia-Sanz J. A. Mikulits W. Livingstone A. Lefkovits I. Mullner E. W. Translational control: a general mechanism for gene regulation during T cell activation. FASEB J. 12 1998 299 306 · doi:10.1096/fasebj.12.03.299
  23. 10.1128/iai.58.8.2613-2620.1990 · doi:10.1128/iai.58.8.2613-2620.1990
  24. 10.1128/iai.64.11.4561-4566.1996 · DOI
  25. Gibson F. C. 3rd Onderdonk A. B. Kasper D. L. Tzianabos A. O. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J. Immunol. 160 1998 5000 5006 · DOI
  26. 10.1128/IAI.66.2.650-655.1998 · DOI
  27. Hotchkiss R. S. Swanson P. E. Knudson C. M. Chang K. C. Cobb J. P. Osborne D. F. Zollner K. M. Buchman T. G. Korsmeyer S. J. Karl I. E. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol. 162 1999 4148 4156 · DOI · Paper page
  28. Ishihara Y. Fujii T. Iijima H. Saito K. Matsunaga K. The role of neutrophils as cytotoxic cells in lung metastasis: suppression of tumor cell metastasis by a biological response modifier (PSK). In Vivo 12 1998 175 182
  29. Kasper D. L. Onderdonk A. B. Crabb J. Bartlett J. G. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J. Infect. Dis. 140 1979 724 731 · doi:10.1093/infdis/140.5.724
  30. 10.1128/AAC.42.3.545 · DOI
  31. Knoflach A. Azuma H. Magee C. Denton M. Murphy B. Iyengar A. Buelow R. Sayegh M. H. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model. J. Am. Soc. Nephrol. 10 1999 1059 1066 · doi:10.1681/asn.v1051059
  32. Konopski Z. Seljelid R. Eskeland T. Cytokines and PGE2 modulate the phagocytic function of the beta-glucan receptor in macrophages. Scand. J. Immunol. 37 1993 587 592 · doi:10.1111/j.1365-3083.1993.tb02576.x
  33. Kopydlowski K. M. Salkowski C. A. Cody M. J. van Rooijen N. Major J. Hamilton T. A. Vogel S. N. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J. Immunol. 163 1999 1537 1544 · DOI · Paper page
  34. Lahnborg G. Hedstrom K. G. Nord C. E. The effect of glucan--a host resistance activator--and ampicillin on experimental intraabdominal sepsis. J. Reticuloendothel. Soc. 32 1982 347 353
  35. Lahnborg G. Hedstrom K. G. Nord C. E. Glucan-induced enhancement of host resistance in experimental intraabdominal sepsis. Eur. Surg. Res. 14 1982 401 408 · doi:10.1159/000128314
  36. Liang J. Melican D. Cafro L. Palace G. Fisette L. Armstrong R. Patchen M. L. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int. J. Immunopharmacol. 20 1998 595 614 · DOI
  37. Lombardi G. Sidhu S. Batchelor R. Lechler R. Anergic T cells as suppressor cells in vitro. Science 264 1994 1587 1589 · DOI · Paper page
  38. Matsunaga K. Hosokawa A. Oohara M. Sugita N. Harada M. Nomoto K. Direct action of a protein-bound polysaccharide, PSK, on transforming growth factor-beta. Immunopharmacology 40 1998 219 230 · DOI
  39. Muller A. Ensley H. Pretus H. McNamee R. Jones E. McLaughlin E. Chandley W. Browder W. Lowman D. Williams D. The application of various protic acids in the extraction of (1→3)-beta-d-glucan from Saccharomyces cerevisiae. Carbohydr. Res. 299 1997 203 208 · DOI
  40. Muller A. Rice P. J. Ensley H. E. Coogan P. S. Kalbfleisch J. H. Kelle J. L. Love E. J. Portera C. A. Ha T. Browder I. W. Williams D. L. Receptor binding and internalization of a water-soluble (1-3)-13-glucan biologic response modifier in two monocyte/macrophage cell lines. J. Immunol. 156 1996 3418 3425 · DOI
  41. 10.1128/iai.62.2.377-383.1994 · DOI
  42. Ng T. B. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen. Pharmacol. 30 1998 1 4 · DOI · Paper page
  43. 10.1128/iai.60.4.1642-1647.1992 · doi:10.1128/iai.60.4.1642-1647.1992
  44. Onderdonk A. B. Kasper D. L. Cisneros R. L. Bartlett J. G. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J. Infect. Dis. 136 1977 82 89 · DOI · Paper page
  45. Onderdonk A. B. Markham R. B. Zaleznik D. F. Cisneros R. L. Kasper D. L. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J. Clin. Investig. 69 1982 9 16 · DOI
  46. 10.1128/iai.10.6.1256-1259.1974 · doi:10.1128/iai.10.6.1256-1259.1974
  47. Patchen M. L. Lotzova E. Modulation of murine hemopoiesis by glucan. Exp. Hematol. 8 1980 409 422
  48. Riggi S. J. DiLuzio N. R. Identification of a reticuloendothelial stimulating agent in zymosan. Am. J. Physiol. 200 1961 297 300 · doi:10.1152/ajplegacy.1961.200.2.297
  49. Ross G. D. Cain J. A. Myones B. L. Newman S. L. Lachmann P. J. Specificity of membrane complement receptor type three (CR3) for beta-glucans. Complement 4 1987 61 74 · DOI · Paper page
  50. Ryan K. R. Evavold B. D. Persistence of peptide-induced CD4+ T cell anergy in vitro. J. Exp. Med. 187 1998 89 96 · doi:10.1084/jem.187.1.89
  51. Schrager H. M. Alberti S. Cywes C. Dougherty G. J. Wessels M. R. Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J. Clin. Investig. 101 1998 1708 1716 · DOI · Paper page
  52. Shapiro M. E. Kasper D. L. Zaleznik D. F. Spriggs S. Onderdonk A. B. Finberg R. W. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J. Immunol. 137 1986 341 346 · doi:10.4049/jimmunol.137.1.341
  53. Shapiro M. E. Onderdonk A. B. Kasper D. L. Finberg R. W. Celluar immunity to Bacteroides fragilis capsular polysaccharide. J. Exp. Med. 154 1982 1188 1197 · DOI
  54. Siegelman M. H. DeGrendele H. C. Estess P. Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leukoc. Biol. 66 1999 315 321 · DOI · Paper page
  55. Soltys J. Quinn M. T. Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan. Infect. Immun. 67 1999 244 252 · DOI
  56. Stashenko P. Wang C. Y. Riley E. Wu Y. Ostroff G. Niederman R. Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG glucan. J. Dent. Res. 74 1995 323 330 · DOI
  57. Steinhauser M. L. Hogaboam C. M. Kunkel S. L. Lukacs N. W. Strieter R. M. Standiford T. J. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 162 1999 392 399 · DOI · Paper page
  58. 10.1016/S0167-7799(97)01139-6 · DOI · Paper page
  59. Thornton A. M. Shevach E. M. CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188 1998 287 296 · DOI · Paper page
  60. Tzianabos A. O. Cisneros R. L. Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria. Ann. N. Y. Acad. Sci. 797 1996 285 287 · doi:10.1111/j.1749-6632.1996.tb52980.x
  61. 10.1086/515594 · DOI
  62. Tzianabos A. O. Kasper D. L. Cisneros R. L. Smith R. S. Onderdonk A. B. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J. Clin. Investig. 96 1995 2727 2731 · DOI
  63. 10.1126/science.8211161 · DOI · Paper page
  64. 10.1128/iai.62.11.4881-4886.1994 · DOI
  65. Tzianabos A. O. Pantosti A. Baumann H. Brisson J. R. Jennings H. J. Kasper D. L. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J. Biol. Chem. 267 1992 18230 18235 · DOI
  66. Tzianabos A. O. Russell P. R. Onderdonk A. B. Gibson F. C. 3rd Cywes C. Chan M. Finberg R. W. Kasper D. L. IL-2 mediates protection against abscess formation in an experimental model of sepsis. J. Immunol. 163 1999 893 897 · DOI
  67. 10.1016/S0145-305X(99)00020-8 · DOI · Paper page
  68. 10.1016/S0162-3109(98)00059-9 · DOI · Paper page
  69. 10.1128/IAI.66.4.1384-1391.1998 · DOI
  70. Wei W. S. Tan J. Q. Guo F. Ghen H. S. Zhou Z. Y. Zhang Z. H. Gui L. Effects of Coriolus versicolor polysaccharides on superoxide dismutase activities in mice. Chung Kuo Yao Li Hsueh Pao 17 1996 174 178
  71. Williams A. Sun X. Fischer J. E. Hasselgren P. O. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 126 1999 744 750 · DOI · Paper page
  72. Williams D. L. Browder I. W. DiLuzio N. R. Immunotherapeutic modification of Escherichia coli-induced experimental peritonitis and bacteremia by glucan. Surgery 93 1983 448 454
  73. Williams D. L. Browder W. McNamee R. Di Luzio N. R. Glucan immunomodulation in experimental E. coli sepsis. Adv. Exp. Med. Biol. 155 1982 701 706 · doi:10.1007/978-1-4684-4394-3_77
  74. Williams D. L. Di Luzio N. R. Glucan induced modification of experimental Staphylococcus aureus infection in normal, leukemic and immunosuppressed mice. Adv. Exp. Med. Biol. 121 1979 291 306
  75. Williams D. L. Pretus H. A. McNamee R. B. Jones E. L. Ensley H. E. Browder I. W. Development of a water-soluble, sulfated (1→3)-beta-d-glucan biological response modifier derived from Saccharomyces cerevisiae. Carbohydr. Res. 235 1992 247 257 · DOI
  76. Williams D. L. Sherwood E. R. Browder I. W. McNamee R. B. Jones E. L. Rakinic J. DiLuzio N. R. Effect of glucan on neutrophil dynamics and immune function in Escherichia coli peritonitis. J. Surg. Res. 44 1988 54 61 · doi:10.1016/0022-4804(88)90122-9
  77. Yan J. Vetvicka V. Xia Y. Coxon A. Carroll M. C. Mayadas T. N. Ross G. D. Beta-glucan, a “specific” biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J. Immunol. 163 1999 3045 3052 · DOI
  78. Yokota M. Kambayashi J. Tsujinaka T. Sakon M. Mori T. Tsuchiya M. Oishi H. Matsuura S. A new method for the quantification of beta-glucan in plasma and its application in the diagnosis of postoperative infection. Jpn. J. Surg. 20 1990 559 566 · doi:10.1007/bf02471013
  79. Zisman D. A. Kunkel S. L. Strieter R. M. Tsai W. C. Bucknell K. Wilkowski J. Standiford T. J. MCP-1 protects mice in lethal endotoxemia. J. Clin. Investig. 99 1997 2832 2836 · DOI · Paper page

Cited by

See all 692

Metadata

Authors
Tzianabos, A. O.
Venue
Clinical Microbiology Reviews
Publisher
American Society for Microbiology
Published
2000-10
Volume
13
Issue
4
Pages
523-533
ISSN
  • 0893-8512 (ISSN-L)
  • 1098-6618
DOI
10.1128/cmr.13.4.523
OpenAlex
W2111773358
Cited by
692
References
1
FWCI
14.31
Type
journal article
Language
en
Open access
bronze
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function. https://app.cochat.ai/papers/10.1128/cmr.13.4.523
The paper
Tzianabos, A. O. (2000). Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.13.4.523

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.